Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of anti-HIV drug regimens with or
without a protease inhibitor (PI) in HIV infected adolescents. It will also determine if
monitoring drug levels and adjusting the dose as necessary improves the effectiveness of
these regimens.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)